Corporate Update | INN
Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to provide the following corporate updates. La Plata Facility Further to ME1’s announcement on 4 September 2023, the Company…
Melodiol Global Health Limited (ASX:ME1) (‘Melodiol’ or ‘the Company’) is pleased to provide the following corporate updates. La Plata Facility Further to ME1’s announcement on 4 September 2023, the Company…
Lobe Sciences (CSE:LOBE,OTCQB:LOBEF) has significantly expanded its portfolio following its acquisition of Altemia & Company. The purchase also sets Lobe Sciences up for revenue generation in the short term, helping…
Albert Labs (CSE:ABRT) is gearing up for the first in-human study of its primary drug target, KRN 101, designed as a one dose treatment for cancer-related anxiety and depression, according…
Wellness, not pharma, will dominate psychedelic market, Gwella CEO saysyoutu.be Canadian psychedelics company Gwella Mushrooms is banking on the wellness market to drive the growth of the emerging psychedelics sector.…
As the Wonderland conference gears up for its second year, Microdose, the organizer of what has become one of the biggest psychedelics events in the world, knows it wants to…